Linda F. Powers
Chief Executive Officer chez NORTHWEST BIOTHERAPEUTICS, INC.
Fortune : 15 M $ au 31/03/2024
Profil
Ms. Linda F.
Powers is a Chairman, President, CEO & Chief Financial Officer at Northwest Biotherapeutics, Inc. and a Managing Director & Co-Founder at Toucan Capital Corp.
She is on the Board of Directors at Moffitt Technology Corp., Q Therapeutic Products, Inc., The Trudeau Institute and Vet-Stem, Inc. Ms. Powers was previously employed as an Independent Director by Q Therapeutics, Inc., a Managing Director by Toucan Capital Fund II LP, an Adjunct Professor by Georgetown University, a Chairman by Maryland Stem Cell Research Commission, and a Director-Task Force by National Academy of Sciences.
She also served on the board at Toucan Capital Fund III LP, Aster Insights, H.
Lee Moffitt Cancer Center & Research Institute, Inc., Pepgen Corp., The Chinese Biopharmaceutical Association, The Genetics Policy Institute Inc and The Rosalind Franklin Society.
She received her undergraduate degree from Princeton University and a graduate degree from Harvard Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/01/2023 | 29 411 759 ( 2,47% ) | 15 M $ | 31/03/2024 |
Postes actifs de Linda F. Powers
| Sociétés | Poste | Début |
|---|---|---|
| NORTHWEST BIOTHERAPEUTICS, INC. | Chief Executive Officer | 08/06/2011 |
Toucan Capital Corp.
 Toucan Capital Corp. Investment ManagersFinance Toucan Capital Corp (Toucan Capital) is a private equity firm founded in 1997 by Linda F. Powers and Robert F. Hemphill. The firm is headquartered in Bethesda, Maryland. | Founder | 01/01/1997 |
Vet-Stem, Inc.
 Vet-Stem, Inc. Pharmaceuticals: MajorHealth Technology Vet-Stem, Inc. develops and tests veterinary pharmaceuticals. The firm develops therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in animals. It offers veterinarian consultation, collection and shipping system, training materials, protocols and information for utilization of regenerative cell therapy, and literature references and background information services .The company was founded by Robert J. Harman and Michael Dale in 2002 and is headquartered in Poway, CA. | Director/Board Member | - |
| The Trudeau Institute | Director/Board Member | - |
| Moffitt Technology Corp. | Director/Board Member | - |
Q Therapeutic Products, Inc.
 Q Therapeutic Products, Inc. Miscellaneous Commercial ServicesCommercial Services Q Therapeutic Products, Inc. develops novel products to treat debilitating and fatal diseases. The company was founded by Dennis B. Farrar and Mahendra S. Rao in 2004 and is headquartered in Salt Lake, UT. | Director/Board Member | - |
Anciens postes connus de Linda F. Powers
| Sociétés | Poste | Fin |
|---|---|---|
Toucan Capital Fund III LP
 Toucan Capital Fund III LP Investment ManagersFinance Toucan Capital Fund III LP seeks investment opportunities in companies located in the United States, primarily in the Mid Atlantic region. The fund focuses on companies operating in the fields of life science and advanced technology. It provides equity financing for seed, early and later stage capital requirements with an investment size of $0.1 and $5 million. It acts as a lead investor, considers co-investments and makes follow-on investments. | Director/Board Member | 01/01/2018 |
Q Therapeutics, Inc.
 Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Director/Board Member | 11/12/2015 |
Toucan Capital Fund II LP
 Toucan Capital Fund II LP Investment ManagersFinance Toucan Capital Fund II LP, an SBIC fund, seeks investment opportunities in companies located in the United States, primarily in the Mid Atlantic region. The fund focuses on companies operating in the fields of life science and advanced technology. It provides equity financing for seed, early and later stage capital requirements with an investment size of $0.1 and $5 million. It acts as a lead investor, considers co-investments and makes follow-on investments. | Corporate Officer/Principal | 01/01/2010 |
| ░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Linda F. Powers
| Princeton University | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NORTHWEST BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 16 |
|---|---|
Pepgen Corp.
 Pepgen Corp. Pharmaceuticals: MajorHealth Technology Pepgen Corp. was a biopharmaceutical company. Its product was Tauferon. The company was founded by C. P. Liu in 1992 and was headquartered in Alameda, CA. | Health Technology |
Toucan Capital Fund II LP
Toucan Capital Fund II LP Investment ManagersFinance Toucan Capital Fund II LP, an SBIC fund, seeks investment opportunities in companies located in the United States, primarily in the Mid Atlantic region. The fund focuses on companies operating in the fields of life science and advanced technology. It provides equity financing for seed, early and later stage capital requirements with an investment size of $0.1 and $5 million. It acts as a lead investor, considers co-investments and makes follow-on investments. | Finance |
Q Therapeutic Products, Inc.
Q Therapeutic Products, Inc. Miscellaneous Commercial ServicesCommercial Services Q Therapeutic Products, Inc. develops novel products to treat debilitating and fatal diseases. The company was founded by Dennis B. Farrar and Mahendra S. Rao in 2004 and is headquartered in Salt Lake, UT. | Commercial Services |
Q Therapeutics, Inc.
Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Health Technology |
Toucan Capital Corp.
Toucan Capital Corp. Investment ManagersFinance Toucan Capital Corp (Toucan Capital) is a private equity firm founded in 1997 by Linda F. Powers and Robert F. Hemphill. The firm is headquartered in Bethesda, Maryland. | Finance |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Commercial Services |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Commercial Services |
Vet-Stem, Inc.
Vet-Stem, Inc. Pharmaceuticals: MajorHealth Technology Vet-Stem, Inc. develops and tests veterinary pharmaceuticals. The firm develops therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in animals. It offers veterinarian consultation, collection and shipping system, training materials, protocols and information for utilization of regenerative cell therapy, and literature references and background information services .The company was founded by Robert J. Harman and Michael Dale in 2002 and is headquartered in Poway, CA. | Health Technology |
| The Trudeau Institute | |
| Moffitt Technology Corp. | |
Aster Insights
 Aster Insights BiotechnologyHealth Technology M2Gen Corp. provides informatics-based solutions to accelerate the discovery, development, and delivery of personalized medicine. Its solutions include Total Cancer Care Protocol and ORIEN Avatar. The company was founded by William S. Dalton in 2006 and is headquartered in Tampa, FL. | Health Technology |
Toucan Capital Fund III LP
Toucan Capital Fund III LP Investment ManagersFinance Toucan Capital Fund III LP seeks investment opportunities in companies located in the United States, primarily in the Mid Atlantic region. The fund focuses on companies operating in the fields of life science and advanced technology. It provides equity financing for seed, early and later stage capital requirements with an investment size of $0.1 and $5 million. It acts as a lead investor, considers co-investments and makes follow-on investments. | Finance |
| The Chinese Biopharmaceutical Association | |
| The Rosalind Franklin Society | |
| The Genetics Policy Institute Inc | Commercial Services |
| Maryland Stem Cell Research Commission | Government |
